Supplier Research

GanedenBC30 Protects Against C. diff.

November 1, 2012

New research has been announced by Ganeden Biotech, Cleveland, OH, which indicated that their probiotic strain GanedenBC30 might aid in the prevention of C. difficile-induced infection (CDI). Recently published in the journal Gut Pathogens, the study demonstrated that Bacillus coagulans GBI-30, 6086 (GanedenBC30) prevents the recurrence of CDI in mice. Additionally, the study found that the mice given GanedenBC30 when re-infected with C.diff experienced more mild symptoms and recovered faster than those mice that were not given the probiotic. Dr. David Keller, vice president of scientific operations at Ganeden Biotech and one of the study’s authors explained, “Currently antibiotics are the primary weapon in the arsenal to fight C. diff. These findings show that the probiotic GanedenBC30 may provide an alternative.” 
For further information: http://www.gutpathogens.com/content/4/1/13/abstract

Related Health Conditions:

Related Market Segments:

  • Nutritional Minerals: Tried & True

    Nutritional Minerals: Tried & True

    Lisa Olivo, Associate Editor||January 3, 2017
    Among the most elementary ingredients in the nutraceuticals space, minerals continue to benefit public health.

  • Brain Saver Solutions

    Brain Saver Solutions

    Alan Richman, Contributing Writer||December 5, 2016
    Lifestyle habits and nutraceuticals may help keep minds alert and memories alive.

  • State of the Industry Update & Outlook for 2017

    State of the Industry Update & Outlook for 2017

    December 5, 2016
    Experts offer their perspectives on the past, present and future of the nutraceuticals market.